| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8538395 | Toxicology and Applied Pharmacology | 2018 | 21 Pages |
Abstract
The present study was designed to evaluate the effects of phenidone (Dual inhibitor of COX-2 and 5-LOX, DuCLOX-2/5 inhibitor) on various aspects of cancer chemoprevention. Treatment with the phenidone was inquested to validate the implications of dual inhibition of arachidonic acid (AA) metabolism against MNU induced mammary gland carcinogenesis. MNU treated rat showed altered hemodynamic profile, distorted cellular architecture, upregulated inflammatory enzyme markers (COX, LOX, Nitric oxide and hydrogen sulfide) and distorted oxidative stress markers (thiobarbituric acid reactive substances, protein carbonyl, superoxide dismutase, catalase and glutathione). Phenidone treatment regulated histological architecture in the experimental animals similar to control. The treatment with phenidone favorably regulated the levels of inflammatory markers, and oxidative stress markers against toxic treatment. Our findings emphasize the potential role of phenidone in suppression of mammary gland carcinoma against the deleterious effects of MNU.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Swetlana Gautam, Soniya Rani, Sara A. Aldossary, Abdulaziz S. Saeedan, Mohd. Nazam Ansari, Gaurav Kaithwas,